BioCorRx Inc. Contracts & Agreements

Form of Warrant (Filed With SEC on December 15, 2023)

Securities Purchase Agreement by and between BioCorRx Inc. and Investor, dated December 8, 2023 (Filed With SEC on December 15, 2023)

Form of Promissory Note (Filed With SEC on December 15, 2023)

Form of Warrant (Filed With SEC on November 16, 2023)

Securities Purchase Agreement by and between BioCorRx Inc. and LGH Investments, LLC, dated November 10, 2023 (Filed With SEC on November 16, 2023)

Form of Promissory Note (Filed With SEC on November 16, 2023)

Form of Warrant (Filed With SEC on April 11, 2023)

Form of Subscription Agreement by and between BioCorRx Inc. and the Investor (Filed With SEC on April 11, 2023)

Form of Warrant (Filed With SEC on April 5, 2023)

Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective March 30, 2023 (Filed With SEC on April 5, 2023)

Form of Exchange Agreement (Filed With SEC on April 5, 2023)

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2023)

Inter-Company License Agreement by and between BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., effective September 2, 2021 (Filed With SEC on March 31, 2023)

Form of Murthy Director Agreement (Filed With SEC on January 23, 2023)

Form of Indemnification Agreement (Filed With SEC on January 23, 2023)

Form of Exchange Agreement entered into with Messrs. Galligan and Lucido in Sept 2022 (Filed With SEC on November 14, 2022)

Form of Warrant (Filed With SEC on May 12, 2022)

Form of Subscription Agreement by and between BioCorRx Inc. and the Purchaser initially effective May 6, 2022 (Filed With SEC on May 12, 2022)

BioCorRx Inc. 2022 Omnibus Securities and Incentive Plan (Filed With SEC on April 28, 2022)

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2022)

Inter-Company License Agreement by and between BioCorRx Inc. and BioCorRx Pharmaceuticals, Inc., effective September 22, 2021 (Filed With SEC on March 31, 2022)

Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts initially effective January 12, 2022 (Filed With SEC on January 19, 2022)

Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on March 31, 2021)

Form of Subscription Agreement by and between BioCorRx Inc. and each of the Lucido and Galligan Trusts entered into on February 23, 2021 (Filed With SEC on February 26, 2021)

Form of Galligan Director Agreement (Filed With SEC on February 22, 2021)

Second Amendment To Lease, dated July 11, 2019, by and between BioCorRx Inc. and Axis Campus Owner, LLC (Filed With SEC on November 14, 2019)

Conversion Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)

Lock-Up Agreement, dated September 30, 2019 by and between BioCorRx Inc., and BICX Holding Company LLC (Filed With SEC on October 4, 2019)

Master Services Agreement by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 24, 2019 (Filed With SEC on June 14, 2019)

Statement of Work 1 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)

Statement of Work 2 by and between BioCorRx Inc. and Charles River Laboratories Inc., dated May 30, 2019 (Filed With SEC on June 14, 2019)

Subscription and Royalty Agreement by and between BioCorRx Inc. and Louis and Carolyn Lucido CRT LLC (Filed With SEC on April 3, 2019)

Subscription and Royalty Agreement by and between BioCorRx Inc. and J and R Galligan Revocable Trust (Filed With SEC on April 3, 2019)

Subscription Agreement dated February 22, 2019 (Filed With SEC on March 8, 2019)

Form of Director Agreement (Filed With SEC on March 7, 2019)

Form of Director Agreement (Filed With SEC on February 22, 2019)

Stock Purchase Agreement, dated December 12, 2018 (Filed With SEC on December 14, 2018)

Form of Promissory Note, dated December 12, 2018 (Filed With SEC on December 14, 2018)

Common Stock Purchase Warrant, dated December 12, 2018 (Filed With SEC on December 14, 2018)

Stock Purchase Agreement, dated November 15, 2018 (Filed With SEC on November 21, 2018)

Form of Promissory Note, dated November 15, 2018 (Filed With SEC on November 21, 2018)

Common Stock Purchase Warrant, dated November 15, 2018 (Filed With SEC on November 21, 2018)

Executive Management Bonus Plan effective June 13, 2018 (Filed With SEC on June 15, 2018)

Executive Service Agreement by and between the Company and Brady Granier, dated June 13, 2018 (Filed With SEC on June 15, 2018)

Executive Service Agreement by and between the Company and Lourdes Felix, dated June 13, 2018 (Filed With SEC on June 15, 2018)

Executive Service Agreement by and between the Company and Tom Welch, dated June 13, 2018 (Filed With SEC on June 15, 2018)

Director Compensation Agreement by and between the Company and Kent Emry, dated June 13, 2018 (Filed With SEC on June 15, 2018)

Director Compensation Agreement by and between the Company and Brady Granier dated June 13, 2018 (Filed With SEC on June 15, 2018)

Director Compensation Agreement by and between the Company and Lourdes Felix, dated June 13, 2018 (Filed With SEC on June 15, 2018)

Form of Subscription Agreement (Filed With SEC on June 6, 2018)

Form of Warrant (Filed With SEC on June 6, 2018)

Form of BioCoRrx Inc. 2018 Equity Incentive Plan (Filed With SEC on May 21, 2018)

Investment Agreement (Filed With SEC on February 20, 2018)

Registration Rights Agreement (Filed With SEC on February 20, 2018)

Form of Promissory Note (Filed With SEC on February 1, 2018)

Form of Subscription Agreement (Filed With SEC on January 23, 2018)

Distributor Agreement with CereCare, LLC, dated December 8, 2017 (Filed With SEC on December 14, 2017)

Second Amendment to Senior Secured Convertible Note Purchase Agreement and Senior Secured Convertible Note by and between the Company and BICX Holding Company LLC, dated June 29,... (Filed With SEC on July 6, 2017)

Settlement Agreement with Lucas Hoppel, dated March 16, 2017 (Filed With SEC on March 22, 2017)

Settlement Agreement with Vista Capital Investments, LLC dated March 20, 2017 (Filed With SEC on March 22, 2017)

First Amendment to Senior Secured Convertible Note Purchase Agreement by and between the Company and BICX Holding Company LLC, dated March 3, 2017 (Filed With SEC on March 9, 2017)

Form of Subscription Agreement entered into between the Company and Investors during February and March 2017 (Filed With SEC on March 9, 2017)

Subscription Agreement with David de Csepel dated December 22, 2016 (Filed With SEC on January 6, 2017)

BIOCORRX INC. 8% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DUE: June 10, 2019 (Filed With SEC on June 21, 2016)

NOTE PURCHASE AGREEMENT among BioCorRx Inc. and BICX HOLDING COMPANY LLC Dated as of June 10, 2016 Table of Contents (Filed With SEC on June 21, 2016)

SECURITY AGREEMENT (Filed With SEC on June 21, 2016)

EXECUTIVE SERVICE AGREEMENT (Filed With SEC on June 21, 2016)

TERMINATION OF ASSET PURCHASE AGREEMENT (Filed With SEC on April 18, 2016)

SECURED PROMISSORY NOTE (Filed With SEC on March 18, 2016)

EXHIBIT 10.1 ASSET PURCHASE AGREEMENT (Filed With SEC on July 7, 2015)

SUBLICENSE RELEASE AGREEMENT (Filed With SEC on July 2, 2015)

SALES AGENCY AGREEMENT (Filed With SEC on March 24, 2015)

EXHIBIT 10.1 SECOND AMENDMENT TO LETTER OF UNDERSTANDING (Filed With SEC on March 18, 2015)

BioWyze Consulting Agreement (Filed With SEC on August 27, 2014)

SETTLEMENT AGREEMENT (Filed With SEC on July 18, 2014)

RESTATEMENT OF SUBLICENSE AGREEMENT (Filed With SEC on July 11, 2014)

FORM OF (Filed With SEC on July 11, 2014)

BIOCORRX INC. AMENDMENT AND RESTATEMENT OF WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK (Filed With SEC on July 11, 2014)

AMENDMENT NO. 1 TO EXECUTIVE SERVICE AGREEMENT (Filed With SEC on July 3, 2014)

CONVERTIBLE DEBT EXCHANGE AGREEMENT (Filed With SEC on July 3, 2014)

AMENDMENT TO AGREEMENT (Filed With SEC on June 25, 2014)

LETTER OF UNDERSTANDING (Filed With SEC on January 2, 2014)

LICENSE AGREEMENT (Filed With SEC on December 16, 2013)

EXHIBIT 10.01 License and Access Agreement By and Between Start Fresh Recovery, Inc. and Fresh Start Private Management Inc. (Filed With SEC on October 7, 2013)

601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705Tel ###-###-#### (Filed With SEC on September 20, 2013)

Share Exchange Agreement, dated October 31, 2011, by and among the Company, the Companys former principal stockholder, FSP and the former principal shareholders of FSP (Filed With SEC on November 4, 2011)

Termination Agreement, dated October 31, 2011, by and among the Company, FSP and Muller (Filed With SEC on November 4, 2011)

Agreement for Service, dated June 1, 2011, by and between FSP and Start Fresh Alcohol Recovery Clinic, Inc (Filed With SEC on November 4, 2011)

License Agreement, dated September 7, 2010, by and between FSP and Trinity Rx Solutions, LLC (Filed With SEC on November 4, 2011)

Agreement for Service, dated January 1, 2010, by and between FSP and New Ways, Inc (Filed With SEC on November 4, 2011)

Advertising Agreement, dated February 1, 2011, by and between FSP and Clear Channel Broadcasting (Filed With SEC on November 4, 2011)

INTELLECTUAL PROPERTY LICENSE AND ASSET PURCHASE AGREEMENT (Filed With SEC on November 22, 2010)

LICENCE AGREEMENT THIS LICENSE AGREEMENT (this "Agreement") is made effective as of the October 28, 2010 (the Effective date) (the "effective date") (Filed With SEC on November 18, 2010)

Category

Industry

Companies

Contracts

BioCorRx Inc. Contracts & Agreements